1 Study Coverage
1.1 Osteoarthritis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Osteoarthritis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Osteoarthritis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Osteoarthritis Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Osteoarthritis Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Osteoarthritis Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Osteoarthritis Drugs Sales by Region
2.4.1 Global Osteoarthritis Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Osteoarthritis Drugs by Region (2023-2028)
2.5 Global Osteoarthritis Drugs Revenue by Region
2.5.1 Global Osteoarthritis Drugs Revenue by Region (2017-2022)
2.5.2 Global Osteoarthritis Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Osteoarthritis Drugs Sales by Manufacturers
3.1.1 Global Top Osteoarthritis Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Osteoarthritis Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Drugs in 2021
3.2 Global Osteoarthritis Drugs Revenue by Manufacturers
3.2.1 Global Osteoarthritis Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Osteoarthritis Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Drugs Revenue in 2021
3.3 Global Osteoarthritis Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Osteoarthritis Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Osteoarthritis Drugs Sales by Type
4.1.1 Global Osteoarthritis Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Osteoarthritis Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Osteoarthritis Drugs Sales Market Share by Type (2017-2028)
4.2 Global Osteoarthritis Drugs Revenue by Type
4.2.1 Global Osteoarthritis Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Osteoarthritis Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Osteoarthritis Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Osteoarthritis Drugs Price by Type
4.3.1 Global Osteoarthritis Drugs Price by Type (2017-2022)
4.3.2 Global Osteoarthritis Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Osteoarthritis Drugs Sales by Application
5.1.1 Global Osteoarthritis Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Osteoarthritis Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Osteoarthritis Drugs Sales Market Share by Application (2017-2028)
5.2 Global Osteoarthritis Drugs Revenue by Application
5.2.1 Global Osteoarthritis Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Osteoarthritis Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Osteoarthritis Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Osteoarthritis Drugs Price by Application
5.3.1 Global Osteoarthritis Drugs Price by Application (2017-2022)
5.3.2 Global Osteoarthritis Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Osteoarthritis Drugs Market Size by Type
6.1.1 North America Osteoarthritis Drugs Sales by Type (2017-2028)
6.1.2 North America Osteoarthritis Drugs Revenue by Type (2017-2028)
6.2 North America Osteoarthritis Drugs Market Size by Application
6.2.1 North America Osteoarthritis Drugs Sales by Application (2017-2028)
6.2.2 North America Osteoarthritis Drugs Revenue by Application (2017-2028)
6.3 North America Osteoarthritis Drugs Market Size by Country
6.3.1 North America Osteoarthritis Drugs Sales by Country (2017-2028)
6.3.2 North America Osteoarthritis Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Osteoarthritis Drugs Market Size by Type
7.1.1 Europe Osteoarthritis Drugs Sales by Type (2017-2028)
7.1.2 Europe Osteoarthritis Drugs Revenue by Type (2017-2028)
7.2 Europe Osteoarthritis Drugs Market Size by Application
7.2.1 Europe Osteoarthritis Drugs Sales by Application (2017-2028)
7.2.2 Europe Osteoarthritis Drugs Revenue by Application (2017-2028)
7.3 Europe Osteoarthritis Drugs Market Size by Country
7.3.1 Europe Osteoarthritis Drugs Sales by Country (2017-2028)
7.3.2 Europe Osteoarthritis Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Osteoarthritis Drugs Market Size by Type
8.1.1 Asia Pacific Osteoarthritis Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Osteoarthritis Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Osteoarthritis Drugs Market Size by Application
8.2.1 Asia Pacific Osteoarthritis Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Osteoarthritis Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Osteoarthritis Drugs Market Size by Region
8.3.1 Asia Pacific Osteoarthritis Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Osteoarthritis Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Osteoarthritis Drugs Market Size by Type
9.1.1 Latin America Osteoarthritis Drugs Sales by Type (2017-2028)
9.1.2 Latin America Osteoarthritis Drugs Revenue by Type (2017-2028)
9.2 Latin America Osteoarthritis Drugs Market Size by Application
9.2.1 Latin America Osteoarthritis Drugs Sales by Application (2017-2028)
9.2.2 Latin America Osteoarthritis Drugs Revenue by Application (2017-2028)
9.3 Latin America Osteoarthritis Drugs Market Size by Country
9.3.1 Latin America Osteoarthritis Drugs Sales by Country (2017-2028)
9.3.2 Latin America Osteoarthritis Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Osteoarthritis Drugs Market Size by Type
10.1.1 Middle East and Africa Osteoarthritis Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Osteoarthritis Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Osteoarthritis Drugs Market Size by Application
10.2.1 Middle East and Africa Osteoarthritis Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Osteoarthritis Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Osteoarthritis Drugs Market Size by Country
10.3.1 Middle East and Africa Osteoarthritis Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Osteoarthritis Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Overview
11.4.3 Abbott Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sanofi Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Flexion Therapeutics
11.7.1 Flexion Therapeutics Corporation Information
11.7.2 Flexion Therapeutics Overview
11.7.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Flexion Therapeutics Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Flexion Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Osteoarthritis Drugs Industry Chain Analysis
12.2 Osteoarthritis Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Osteoarthritis Drugs Production Mode & Process
12.4 Osteoarthritis Drugs Sales and Marketing
12.4.1 Osteoarthritis Drugs Sales Channels
12.4.2 Osteoarthritis Drugs Distributors
12.5 Osteoarthritis Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Osteoarthritis Drugs Industry Trends
13.2 Osteoarthritis Drugs Market Drivers
13.3 Osteoarthritis Drugs Market Challenges
13.4 Osteoarthritis Drugs Market Restraints
14 Key Findings in The Global Osteoarthritis Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Osteoarthritis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injection
Table 4. Major Manufacturers of External
Table 5. Global Osteoarthritis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Osteoarthritis Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Osteoarthritis Drugs Sales by Region (2017-2022) & (MT)
Table 8. Global Osteoarthritis Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Osteoarthritis Drugs Sales by Region (2023-2028) & (MT)
Table 10. Global Osteoarthritis Drugs Sales Market Share by Region (2023-2028)
Table 11. Global Osteoarthritis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Osteoarthritis Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global Osteoarthritis Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Osteoarthritis Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global Osteoarthritis Drugs Sales by Manufacturers (2017-2022) & (MT)
Table 16. Global Osteoarthritis Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global Osteoarthritis Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Osteoarthritis Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. Osteoarthritis Drugs Price by Manufacturers (2017-2022) &(USD/Kg)
Table 20. Global Osteoarthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Osteoarthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Drugs as of 2021)
Table 22. Osteoarthritis Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Osteoarthritis Drugs Product Offered
Table 24. Date of Manufacturers Enter into Osteoarthritis Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Osteoarthritis Drugs Sales by Type (2017-2022) & (MT)
Table 27. Global Osteoarthritis Drugs Sales by Type (2023-2028) & (MT)
Table 28. Global Osteoarthritis Drugs Sales Share by Type (2017-2022)
Table 29. Global Osteoarthritis Drugs Sales Share by Type (2023-2028)
Table 30. Global Osteoarthritis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Osteoarthritis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Osteoarthritis Drugs Revenue Share by Type (2017-2022)
Table 33. Global Osteoarthritis Drugs Revenue Share by Type (2023-2028)
Table 34. Osteoarthritis Drugs Price by Type (2017-2022) & (USD/Kg)
Table 35. Global Osteoarthritis Drugs Price Forecast by Type (2023-2028) & (USD/Kg)
Table 36. Global Osteoarthritis Drugs Sales by Application (2017-2022) & (MT)
Table 37. Global Osteoarthritis Drugs Sales by Application (2023-2028) & (MT)
Table 38. Global Osteoarthritis Drugs Sales Share by Application (2017-2022)
Table 39. Global Osteoarthritis Drugs Sales Share by Application (2023-2028)
Table 40. Global Osteoarthritis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Osteoarthritis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Osteoarthritis Drugs Revenue Share by Application (2017-2022)
Table 43. Global Osteoarthritis Drugs Revenue Share by Application (2023-2028)
Table 44. Osteoarthritis Drugs Price by Application (2017-2022) & (USD/Kg)
Table 45. Global Osteoarthritis Drugs Price Forecast by Application (2023-2028) & (USD/Kg)
Table 46. North America Osteoarthritis Drugs Sales by Type (2017-2022) & (MT)
Table 47. North America Osteoarthritis Drugs Sales by Type (2023-2028) & (MT)
Table 48. North America Osteoarthritis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Osteoarthritis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Osteoarthritis Drugs Sales by Application (2017-2022) & (MT)
Table 51. North America Osteoarthritis Drugs Sales by Application (2023-2028) & (MT)
Table 52. North America Osteoarthritis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Osteoarthritis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Osteoarthritis Drugs Sales by Country (2017-2022) & (MT)
Table 55. North America Osteoarthritis Drugs Sales by Country (2023-2028) & (MT)
Table 56. North America Osteoarthritis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Osteoarthritis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Osteoarthritis Drugs Sales by Type (2017-2022) & (MT)
Table 59. Europe Osteoarthritis Drugs Sales by Type (2023-2028) & (MT)
Table 60. Europe Osteoarthritis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Osteoarthritis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Osteoarthritis Drugs Sales by Application (2017-2022) & (MT)
Table 63. Europe Osteoarthritis Drugs Sales by Application (2023-2028) & (MT)
Table 64. Europe Osteoarthritis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Osteoarthritis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Osteoarthritis Drugs Sales by Country (2017-2022) & (MT)
Table 67. Europe Osteoarthritis Drugs Sales by Country (2023-2028) & (MT)
Table 68. Europe Osteoarthritis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Osteoarthritis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Osteoarthritis Drugs Sales by Type (2017-2022) & (MT)
Table 71. Asia Pacific Osteoarthritis Drugs Sales by Type (2023-2028) & (MT)
Table 72. Asia Pacific Osteoarthritis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Osteoarthritis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Osteoarthritis Drugs Sales by Application (2017-2022) & (MT)
Table 75. Asia Pacific Osteoarthritis Drugs Sales by Application (2023-2028) & (MT)
Table 76. Asia Pacific Osteoarthritis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Osteoarthritis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Osteoarthritis Drugs Sales by Region (2017-2022) & (MT)
Table 79. Asia Pacific Osteoarthritis Drugs Sales by Region (2023-2028) & (MT)
Table 80. Asia Pacific Osteoarthritis Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Osteoarthritis Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Osteoarthritis Drugs Sales by Type (2017-2022) & (MT)
Table 83. Latin America Osteoarthritis Drugs Sales by Type (2023-2028) & (MT)
Table 84. Latin America Osteoarthritis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Osteoarthritis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Osteoarthritis Drugs Sales by Application (2017-2022) & (MT)
Table 87. Latin America Osteoarthritis Drugs Sales by Application (2023-2028) & (MT)
Table 88. Latin America Osteoarthritis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Osteoarthritis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Osteoarthritis Drugs Sales by Country (2017-2022) & (MT)
Table 91. Latin America Osteoarthritis Drugs Sales by Country (2023-2028) & (MT)
Table 92. Latin America Osteoarthritis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Osteoarthritis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Osteoarthritis Drugs Sales by Type (2017-2022) & (MT)
Table 95. Middle East and Africa Osteoarthritis Drugs Sales by Type (2023-2028) & (MT)
Table 96. Middle East and Africa Osteoarthritis Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Osteoarthritis Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Osteoarthritis Drugs Sales by Application (2017-2022) & (MT)
Table 99. Middle East and Africa Osteoarthritis Drugs Sales by Application (2023-2028) & (MT)
Table 100. Middle East and Africa Osteoarthritis Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Osteoarthritis Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Osteoarthritis Drugs Sales by Country (2017-2022) & (MT)
Table 103. Middle East and Africa Osteoarthritis Drugs Sales by Country (2023-2028) & (MT)
Table 104. Middle East and Africa Osteoarthritis Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Osteoarthritis Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Johnson & Johnson Corporation Information
Table 107. Johnson & Johnson Description and Major Businesses
Table 108. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 109. Johnson & Johnson Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Johnson & Johnson Recent Developments
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 114. Pfizer Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Eli Lilly Corporation Information
Table 117. Eli Lilly Description and Major Businesses
Table 118. Eli Lilly Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 119. Eli Lilly Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Eli Lilly Recent Developments
Table 121. Abbott Corporation Information
Table 122. Abbott Description and Major Businesses
Table 123. Abbott Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 124. Abbott Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Abbott Recent Developments
Table 126. GlaxoSmithKline Corporation Information
Table 127. GlaxoSmithKline Description and Major Businesses
Table 128. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 129. GlaxoSmithKline Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. GlaxoSmithKline Recent Developments
Table 131. Sanofi Corporation Information
Table 132. Sanofi Description and Major Businesses
Table 133. Sanofi Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 134. Sanofi Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Sanofi Recent Developments
Table 136. Flexion Therapeutics Corporation Information
Table 137. Flexion Therapeutics Description and Major Businesses
Table 138. Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 139. Flexion Therapeutics Osteoarthritis Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Flexion Therapeutics Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Osteoarthritis Drugs Distributors List
Table 144. Osteoarthritis Drugs Customers List
Table 145. Osteoarthritis Drugs Market Trends
Table 146. Osteoarthritis Drugs Market Drivers
Table 147. Osteoarthritis Drugs Market Challenges
Table 148. Osteoarthritis Drugs Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Osteoarthritis Drugs Product Picture
Figure 3. Global Osteoarthritis Drugs Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. External Product Picture
Figure 6. Global Osteoarthritis Drugs Market Share by Application in 2021 & 2028
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Osteoarthritis Drugs Report Years Considered
Figure 11. Global Osteoarthritis Drugs Sales 2017-2028 (MT)
Figure 12. Global Osteoarthritis Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Osteoarthritis Drugs Revenue 2017-2028 (US$ Million)
Figure 14. Global Osteoarthritis Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Osteoarthritis Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global Osteoarthritis Drugs Sales Market Share by Region (2023-2028)
Figure 17. North America Osteoarthritis Drugs Sales YoY (2017-2028) & (MT)
Figure 18. North America Osteoarthritis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Osteoarthritis Drugs Sales YoY (2017-2028) & (MT)
Figure 20. Europe Osteoarthritis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Osteoarthritis Drugs Sales YoY (2017-2028) & (MT)
Figure 22. Asia-Pacific Osteoarthritis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Osteoarthritis Drugs Sales YoY (2017-2028) & (MT)
Figure 24. Latin America Osteoarthritis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Osteoarthritis Drugs Sales YoY (2017-2028) & (MT)
Figure 26. Middle East & Africa Osteoarthritis Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Osteoarthritis Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Osteoarthritis Drugs in the World: Market Share by Osteoarthritis Drugs Revenue in 2021
Figure 29. Global Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Osteoarthritis Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Osteoarthritis Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Osteoarthritis Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Osteoarthritis Drugs Revenue Market Share by Application (2017-2028)
Figure 34. North America Osteoarthritis Drugs Sales Market Share by Type (2017-2028)
Figure 35. North America Osteoarthritis Drugs Revenue Market Share by Type (2017-2028)
Figure 36. North America Osteoarthritis Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Osteoarthritis Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Osteoarthritis Drugs Sales Share by Country (2017-2028)
Figure 39. North America Osteoarthritis Drugs Revenue Share by Country (2017-2028)
Figure 40. U.S. Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Osteoarthritis Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Osteoarthritis Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe Osteoarthritis Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Osteoarthritis Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe Osteoarthritis Drugs Sales Share by Country (2017-2028)
Figure 47. Europe Osteoarthritis Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Osteoarthritis Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Osteoarthritis Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Osteoarthritis Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Osteoarthritis Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Osteoarthritis Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Osteoarthritis Drugs Revenue Share by Region (2017-2028)
Figure 59. China Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Osteoarthritis Drugs Sales Market Share by Type (2017-2028)
Figure 70. Latin America Osteoarthritis Drugs Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Osteoarthritis Drugs Sales Market Share by Application (2017-2028)
Figure 72. Latin America Osteoarthritis Drugs Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Osteoarthritis Drugs Sales Share by Country (2017-2028)
Figure 74. Latin America Osteoarthritis Drugs Revenue Share by Country (2017-2028)
Figure 75. Mexico Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Osteoarthritis Drugs Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Osteoarthritis Drugs Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Osteoarthritis Drugs Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Osteoarthritis Drugs Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Osteoarthritis Drugs Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Osteoarthritis Drugs Revenue Share by Country (2017-2028)
Figure 84. Turkey Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Osteoarthritis Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Osteoarthritis Drugs Value Chain
Figure 88. Osteoarthritis Drugs Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
